Regional citrate anticoagulation in patients with liver failure supported by a molecular adsorbent recirculating system

Critical Care Medicine

Volumn 39, Issue 2, 2011, Pages 273-279

  Faybik, Peter ^a   Hetz, Hubert ^a   Mitterer, Gerfried ^a   Krenn, Claus Georg ^a   Schiefer, Judith ^a   Funk, Georg Christian ^b   Bacher, Andreas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b OTTO WAGNER HOSPITAL   (Austria)

Author keywords

acid base balance; citrate; ionized calcium; liver failure; regional anticoagulation

Indexed keywords

CALCIUM; CALCIUM CHLORIDE; CITRIC ACID; ELECTROLYTE;

ACID BASE BALANCE; ADULT; ALBUMIN DIALYSIS; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING; BLOOD FLOW; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CRITICALLY ILL PATIENT; DIALYSATE; ELECTROLYTE BALANCE; ELECTROLYTE DISTURBANCE; HUMAN; INFUSION RATE; LIVER FAILURE; LIVER SUPPORT; PRIORITY JOURNAL;

EID: 79251586161     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181fee8a4     Document Type: Article

References (39)

1. Amitrano L, Guardascione MA, Brancaccio V, et al: Coagulation disorders in liver disease. Semin Liver Dis 2002; 22:83-96
2. Wada H, Usui M, Sakuragawa N: Hemostatic abnormalities and liver diseases. Semin Thromb Hemost 2008; 34:772-778
3. Oudemans-van Straaten HM, Bosman RJ, Koopmans M, et al: Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009; 37:1-9
4. Monchi M, Berghmans D, Ledoux D, et al: Citrate vs heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study. Intensive Care Med 2004; 30:260-265
5. Kutsogiannis DJ, Gibney RT, Stollery D, et al: Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005; 67:2361-2367
6. Betjes MG, van Oosterom D, van Agteren M, et al: Regional citrate versus heparin anticoagulation during venovenous hemofiltration in patients at low risk for bleeding: Similar hemofilter but significantly less bleeding. J Nephro 2007; 20:602-608
7. Apsner R, Schwarzenhofer M, Derfler K, et al: Impairment of citrate metabolism in acute hepatic failure. Wien Klin Wochenschr 1997; 109:13-127
8. Kramer L, Bauer E, Joukhadar C, et al: Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003; 31:2450-2455
9. Meier-Kriesche HU, Gitomer J, Finkel K, et al: Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001; 29:748-752
10. Morgera S, Schneider M, Slowinski T, et al: A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med 2009; 37:2018-2024
11. Schmidt LE, Wang LP, Hansen BA, et al: Systemic hemodynamic effects of treatment with the molecular adsorbent recirculating system in patients with hyperacute liver failure: A prospective controlled trial. Liver Transpl 2003; 9:290-297
12. Schmidt LE, Sorensen VR, Svendsen LB, et al: Hemodynamic changes during a single treatment with the molecular adsorbent recirculating system in patients with acute-onchronic liver failure. Liver Transpl 2001; 7:1034-1039
13. Sen S, Davies NA, Mookerjee RP, et al: Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: A randomized controlled study. Liver Transpl 2004; 10: 1109-1119
14. Sen S, Williams R, Jalan R: Emerging indications for albumin dialysis. Am J Gastroenterol 2005; 100:468-475
15. Steiner C, Sen S, Stange J, et al: Binding of bilirubin and bromosulphthalein to albumin: Implications for understanding the pathophysiology of liver failure and its management. Liver Transpl 2004; 10:1531-1538
16. Heemann U, Treichel U, Loock J, et al: Albumin dialysis in cirrhosis with superimposed acute liver injury: A prospective, controlled study. Hepatology 2002; 36:949-958
17. Mitzner SR, Stange J, Klammt S, et al: Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6:277-286
18. Saliba F, Camus C, Durand, et al: Predictive factors of transplant free survival in patients with fulminant and subfulminant hepatic failure: Results from a randomized controlled multicenter trial. J Hepatol 2009; 50(Suppl 1):S89
19. Thiery J, Fiedler GM: The incorrect laboratory result. Common misinterpretation of laboratory results. Internist 2004; 45: 437-454
20. Fencl V, Jabor A, Kazda A, et al: Diagnosis of metabolic acid-base disturbances in critically ill patients. Am J Respir Crit Care Med 2000; 162:2246-2251
21. Figge J, Rossing TH, Fencl V: The role of serum proteins in acid-base equilibria. J Lab Clin Med 1991; 117:453-467
22. Figge J, Mydosh T, Fencl V: Serum proteins and acid-base equilibria: A follow up. J Lab Clin Med 1992; 120:713-719
23. Gilfix BM, Bique M, Magder S: A physical chemical approach to the analysis of acidbase balance in the clinical setting. J Crit Care 1993; 8:187-197
24. Funk GC, Doberer D, Fuhrmann V, et al: The acidifying effect of lactate is neutralized by the alkalizing effect of hypoalbuminemia in non-paracetamol-induced acute liver failure. J Hep 2006; 45:387-392
25. Faybik P, Bacher A, Kozek-Langenecker SA, et al: Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: An observational study. Crit Care 2006; 10:R24
26. Dennen P, Douglas IS, Anderson R: Acute kidney injury in the intensive care unit: An update and primer for the intensivist. Crit Care Med 2010; 38:261-275
27. Opatrny K, Richtrova P, Polanska K, et al: Citrate anticoagulation control by ionized calcium levels does not prevent hemostasis and complement activation during hemodialysis. Artif Organs 2007; 31:200-207
28. Sogaard KK, Horvath-Puho E, Gronbaek H, et al: Risk of venous thromboembolism in patients with liver disease: A nationwide population- based case-control study. Am J Gastroenterol 2009; 104:96-101
29. Northrup PG, McMahon MM, Ruhl AP, et al: Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol 2006; 101:1524-1528
30. Doria C, Mandala L, Smith JD, et al: Thromboelastography used to assess coagulation during treatment with molecular adsorbent recirculating system. Clin Transplant 2004; 18:365-371
31. Kozek-Langenecker SA: Anticoagulation with prostaglandins during extracorporeal circulation. Wien Klin Wochenschr 1999; 111:129-140
32. Gritters M, Grooteman MPC, Schoorl M, et al: Citrate anticoagulation abolishes degranulation of polymorphonuclear cells and platelets and reduces oxidative stress during haemodialysis. Nephrol Dial Transplant 2006; 21:153-159
33. Gabutti L, Ferrari N, Mombelli G, et al: The favorable effect of regional citrate anticoagulation on interleukin-1beta release is dissociated from both coagulation and complement activation. J Nephrol 2004; 17: 819-825
34. Meier-Kriesche HU, Finkel KW, Gitomer JJ, et al: Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Am J Kidney Dis 1999; 33:E8
35. Palsson R, Niles JL: Regional citrate anticoagulation in continuous venovenous hemo- filtration with a high risk of bleeding. Kidney Int 1999; 55:1991-1997
36. Morath C, Miftari N, Dikow R, et al: Sodium citrate anticoagulation during sustained low efficiency dialysis (SLED) in patients with acute renal failure and severely impaired liver function. Nephrol Dial Transplant 2008; 23:421-422
37. Naka T, Bellomo R, Morimatsu H, et al: Acid-base balance during continuous venovenous hemofiltration: The impact of severe hepatic failure. Int J Artif Organs 2006; 29:668-674
38. Naka T, Bellomo R, Morimatsu H, et al: Acidbase balance in combined severe hepatic and renal failure: A quantitative analysis. Int J Artif Organs 2008; 31:288-294.
39. Crit Care Med 2011 Vol. 39, No. 2. 279